title: Cutaneous metastasis of bladder sarcoma: when should we consider this hypothesis? A review of the literature.
abstract: The incidence of cutaneous metastases is approximately 0.7 to 10%, while in metastases of urothelial origin the incidence is less than 1%. Transitional cell carcinoma is the most common of the genitourinary tract tumors. Sarcoma of the bladder is rare (0.3%). It can involve multiple clinical presentations, with a nodule being the most common. Diagnosis is made by a combination of medical history, clinical examination and histopathology. The treatment is surgical. The prognosis is very uncertain and depends on a multidisciplinary approach.
authors.affiliation: Instituto de Dermatologia Professor Rubem David Azulay, Santa casa de Misericórdia do Rio de Janeiro, Brasil. marcinha_ralopes@yahoo.com.br
authors.forename: Márcia
authors.initials: M
authors.lastname: Lopes
authors.forename: Carlos Baptista
authors.initials: CB
authors.lastname: Barcaui
authors.forename: Airá Novello
authors.initials: AN
authors.lastname: Vilar
mesh_terms: D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000556:secondary*; D012878:Skin Neoplasms / Q000556:secondary*; D001749:Urinary Bladder Neoplasms / Q000473:pathology*